{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:17:40Z","timestamp":1767975460000,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4055-7","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T13:03:59Z","timestamp":1557839039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Guragae zone southern Central Ethiopia"],"prefix":"10.1186","volume":"19","author":[{"given":"Teha","family":"Shumbej","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulewhab","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulsemed","family":"Worku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fitsum","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habtamu","family":"Weldesenbet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"4055_CR1","unstructured":"WHO. Global technical strategy for malaria 2016-2030. World Health Organization; 2015 Nov 4."},{"issue":"7","key":"4055_CR2","doi-asserted-by":"publisher","first-page":"e11692","DOI":"10.1371\/journal.pone.0011692","volume":"5","author":"Jimee Hwang","year":"2010","unstructured":"Hwang J, Graves PM, Jima D, Reithinger R, Kachur SP, Ethiopia MIS Working Group. Knowledge of malaria and its association with malaria-related behaviors\u2014results from the Malaria Indicator Survey, Ethiopia, 2007. PLoS One. 2010;5(7):e11692.","journal-title":"PLoS ONE"},{"key":"4055_CR3","unstructured":"WHO. World malaria report 2015. World Health Organization; 2016 Jan 30."},{"key":"4055_CR4","first-page":"413","volume-title":"Antimicrobial Resistance in Developing Countries","author":"Paul N. Newton","year":"2009","unstructured":"Newton PN, Fernandez FM, Green MD, Primo-Carpenter J, White NJ. Counterfeit and substandard anti-infectives in developing countries. In Antimicrobial resistance in developing countries. New York: Springer; 2010. p. 413\u201343."},{"issue":"6 Suppl","key":"4055_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","volume":"77","author":"RN Price","year":"2007","unstructured":"Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. AM J TROP HYG. 2007;77(6 Suppl):79\u201387.","journal-title":"AM J TROP HYG"},{"key":"4055_CR6","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. World Health Organization; 2009. \n                    http:\/\/www.who.int\/iris\/handle\/10665\/44048\n                    \n                  ."},{"issue":"4","key":"4055_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1590\/S0037-86822007000400026","volume":"40","author":"MVG Lacerda","year":"2007","unstructured":"Lacerda MVG, Zackiewicz C, Alecrim WD, Alecrim MGC. The neglected Plasmodium vivax: are researchers from endemic areas really concerned about new treatment options? Rev Soc Bras Med Trop. 2007;40(4):489\u201390.","journal-title":"Rev Soc Bras Med Trop"},{"key":"4055_CR8","unstructured":"Global report on antimalarial drug efficacy and drug resistance 2000\u20132010: WHO, World Health Organization; 2010."},{"issue":"2","key":"4055_CR9","first-page":"8","volume":"7","author":"A Heidari","year":"2012","unstructured":"Heidari A, Keshavarz H, Shojaee S, Raeisi A, Dittrich S. In vivo susceptibility of Plasmodium vivax to chloroquine in southeastern Iran. IJP. 2012;7(2):8.","journal-title":"IJP"},{"issue":"2","key":"4055_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4269\/ajtmh.2009.81.338","volume":"81","author":"I Sutanto","year":"2009","unstructured":"Sutanto I, Suprijanto S, Manoempil P, Baird JK. Resistance to chloroquine by Plasmodium vivax at Alor in the lesser Sundas archipelago in eastern Indonesia. AM J TROP HYG. 2009;81(2):338\u201342.","journal-title":"AM J TROP HYG"},{"issue":"1","key":"4055_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12936-015-1041-4","volume":"14","author":"S Getachew","year":"2015","unstructured":"Getachew S, Thriemer K, Auburn S, Abera A, Gadisa E, Aseffa A, et al. Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia. Malar J. 2015;14(1):525.","journal-title":"Malar J"},{"issue":"1","key":"4055_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1475-2875-8-177","volume":"8","author":"T Ketema","year":"2009","unstructured":"Ketema T, Bacha K, Birhanu T, Petros B. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-West Ethiopia. Malar J. 2009;8(1):177.","journal-title":"Malar J"},{"issue":"1","key":"4055_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1475-2875-9-58","volume":"9","author":"D Jima","year":"2010","unstructured":"Jima D, Getachew A, Bilak H, Steketee RW, Emerson PM, Graves PM, et al. Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions. Malar J. 2010;9(1):58.","journal-title":"Malar J"},{"issue":"6","key":"4055_CR14","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/QCO.0b013e32834c61e3","volume":"24","author":"RN Price","year":"2011","unstructured":"Price RN, Douglas NM, Anstey NM, von Seidlein L. Plasmodium vivax treatments: what are we looking for? Curr Opin Infect Dis. 2011;24(6):578.","journal-title":"Curr Opin Infect Dis"},{"key":"4055_CR15","unstructured":"FMOH. Malaria treatment guideline: Federal Democratic Republic of Ethiopia Ministry of Health; 2004."},{"issue":"4","key":"4055_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4269\/ajtmh.1998.59.513","volume":"59","author":"DJ Fryauff","year":"1998","unstructured":"Fryauff DJ, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, et al. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. AM J TROP HYG. 1998;59(4):513\u20138.","journal-title":"AM J TROP HYG"},{"issue":"1","key":"4055_CR17","first-page":"01","volume":"7","author":"A Alelign","year":"2016","unstructured":"Alelign A, Dejene T. Current status of malaria in Ethiopia: evaluation of the burden, factors for transmission and prevention methods. Acta Parasitologica Globalis. 2016;7(1):01\u20136.","journal-title":"Acta Parasitologica Globalis"},{"issue":"1","key":"4055_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12936-015-0983-x","volume":"14","author":"M Assefa","year":"2015","unstructured":"Assefa M, Eshetu T, Biruksew A. Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana health care Centre, southern Ethiopia. Malar J. 2015;14(1):458.","journal-title":"Malar J"},{"issue":"5","key":"4055_CR19","first-page":"556","volume":"90","author":"AN Tulu","year":"1996","unstructured":"Tulu AN, Webber RH, Schellenberg JA, Bradley DJ. Failure of chloroquine treatment for malaria in the highlands of Ethiopia. TRSTMH. 1996;90(5):556\u20137.","journal-title":"TRSTMH"},{"issue":"1","key":"4055_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-3305-4-46","volume":"4","author":"T Ketema","year":"2011","unstructured":"Ketema T, Getahun K, Bacha K. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia. Parasit Vectors. 2011;4(1):46.","journal-title":"Parasit Vectors"},{"issue":"1","key":"4055_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1475-2875-7-220","volume":"7","author":"H Teka","year":"2008","unstructured":"Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, et al. Chloroquine-resistant plasmodium vivax malaria in Debre Zeit, Ethiopia. Malaria J. 2008;7(1):220.","journal-title":"Malaria J"},{"issue":"4","key":"4055_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4269\/ajtmh.2003.68.416","volume":"68","author":"IW Sumawinata","year":"2003","unstructured":"Sumawinata IW, Leksana B, Sutamihardja A, Subianto B, Fryauff DJ, Baird JK. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. AM J TROP HYG. 2003;68(4):416\u201320.","journal-title":"AM J TROP HYG"},{"issue":"1","key":"4055_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","volume":"16","author":"NJ White","year":"2017","unstructured":"White NJ. Malaria parasite clearance. Malar J. 2017;16(1):88.","journal-title":"Malar J"},{"key":"4055_CR24","unstructured":"WHO. Guidelines for the treatment of malaria. World Health Organization; 2015 Aug 13."},{"issue":"9918","key":"4055_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(13)60024-0","volume":"383","author":"N White","year":"2014","unstructured":"White N, Pukrittayakamee S, Hien T, Faiz M, Mokuolu O, Dondorp A. Erratum: Malaria. Lancet. 2014;383(9918):696.","journal-title":"Lancet"},{"issue":"6","key":"4055_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1096\/fj.05-5122fje","volume":"20","author":"LR Moore","year":"2006","unstructured":"Moore LR, Fujioka H, Williams PS, Chalmers JJ, Grimberg B, Zimmerman PA, et al. Hemoglobin degradation in malaria-infected erythrocytes determined from live cell magnetophoresis. FASEB J. 2006;20(6):747\u20139.","journal-title":"FASEB J"},{"issue":"11","key":"4055_CR27","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.48.11.4075-4083.2004","volume":"48","author":"JK Baird","year":"2004","unstructured":"Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004;48(11):4075\u201383.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4055-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4055-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4055-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T23:06:07Z","timestamp":1589324767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4055-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4055"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4055-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"1 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocols were reviewed and approved by the Ethical Review Committee of Wolkite University (Ref.No.WR 5669\/32\/09). Letters of permission was obtained from Guragea Zone Health Department and each Woredas\u2019 Health Office. The objective as well as the nature of the study was explained to the participant and written informed consent was obtained from each participant or their guardians for patient younger than 18\u2009years. Those patients who didn\u2019t respond to the therapeutic dose of chloroquine were re-treated with quinine as recommended by national guideline [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"413"}}